EGFR and neoplasm: Some of the genomic alterations detected in WSE-related NSCLC in our study were concurrent, represented mostly by ATM mutations in combination with another tumor suppressor, like SMARCB1 and oncogenes such as RET, KDR and EGFR exon 7 [29].